Mesirow Financial Investment Management’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-15,805
| Closed | -$232K | – | 73 |
|
|
2020
Q2 | $232K | Buy |
15,805
+670
| +4% | +$9.84K | 1.09% | 61 |
|
|
2020
Q1 | $178K | Sell |
15,135
-160
| -1% | -$1.88K | 1.12% | 56 |
|
|
2019
Q4 | $359K | Sell |
15,295
-7,370
| -33% | -$173K | 1.52% | 37 |
|
|
2019
Q3 | $419K | Sell |
22,665
-1,447
| -6% | -$26.8K | 1.76% | 24 |
|
|
2019
Q2 | $430K | Buy |
24,112
+4,559
| +23% | +$81.3K | 1.57% | 41 |
|
|
2019
Q1 | $478K | Buy |
19,553
+6,254
| +47% | +$153K | 1.9% | 19 |
|
|
2018
Q4 | $345K | Buy |
13,299
+2,603
| +24% | +$67.5K | 2.23% | 14 |
|
|
2018
Q3 | $339K | Sell |
10,696
-10,537
| -50% | -$334K | 1.75% | 29 |
|
|
2018
Q2 | $825K | Sell |
21,233
-12,156
| -36% | -$472K | 3.67% | 1 |
|
|
2018
Q1 | $922K | Sell |
33,389
-486
| -1% | -$13.4K | 3.88% | 1 |
|
|
2017
Q4 | $613K | Buy |
33,875
+601
| +2% | +$10.9K | 2.78% | 4 |
|
|
2017
Q3 | $537K | Sell |
33,274
-3,470
| -9% | -$56K | 2.53% | 8 |
|
|
2017
Q2 | $509K | Buy |
+36,744
| New | +$509K | 2.4% | 10 |
|